All stock lists
Anheuser-Busch Inbev SA Sponsor (New York Stock Exchange:BUD)
BE · Delayed Price · Currency is USD
Consumer Defensive · Beverages - Alcoholic
80.98-0.39 (-0.48%)
Market cap
$161B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 1, 2009
Website
Insider Score
––Not scored
BUD Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From BUD’s reported statements · Q2 2026 (trailing 12 months)
Profitability17 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $122.43B
- Net income
- $15.96B
- Net margin
- 13.0%
Leverage13 / 20
A manageable debt load.
- Total debt
- $72.32B
- Cash
- $7.55B
- Net debt / EBITDA
- 1.40x
Liquidity2 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $22.24B
- Current liabilities
- $33.48B
- Current ratio
- 0.66
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $32.55B
- Free cash flow
- $25.38B
- FCF margin
- 20.7%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 1977.7M
- Share growth (1y)
- -1.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BUD Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 31.93 B | 30.61 B | 30.01 B | 29.89 B | 29.88 B | 30.05 B |
| Revenue Growth (YoY) | 6.85 % | 1.87 % | 2.30 % | 0.43 % | 6.61 % | 5.53 % |
| Cost of Revenue | 13.70 B | 13.50 B | 13.12 B | 13.32 B | 13.42 B | 13.86 B |
| Gross Profit | 18.23 B | 17.10 B | 16.89 B | 16.56 B | 16.46 B | 16.19 B |
| SG&A Expense | 6.50 B | 9.30 B | 17.62 B | 9.09 B | 9.25 B | 9.12 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.53 B | 9.30 B | 1.88 B | 8.62 B | 8.91 B | 8.67 B |
| Operating Income | 8.69 B | 7.81 B | 15.01 B | 7.94 B | 7.55 B | 7.52 B |
| Pretax Income | 8.77 B | 5.34 B | 5.53 B | 5.79 B | 4.78 B | 5.28 B |
| Tax Provision | 1.70 B | 1.44 B | 1.48 B | 1.61 B | 1.55 B | 1.04 B |
| Net Income | 6.31 B | 3.01 B | 3.35 B | 3.29 B | 2.56 B | 3.36 B |
| EPS (Basic) | 3.19 | 1.52 | 1.68 | 1.64 | 1.27 | 1.67 |
| EPS (Diluted) | 3.19 | 1.52 | 1.68 | 1.64 | 1.27 | 1.67 |
| Shares Outstanding | 1.98 B | 1.98 B | 1.99 B | 2.00 B | 2.00 B | 1.98 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.